Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.090 AUD
−17.66 M AUD
0.00 AUD
156.95 M
About RECCE PHARMACEUTICALS LTD
Sector
CEO
James Graham
Headquarters
Sydney
Website
Founded
2007
ISIN
AU000000RCE5
FIGI
BBG009XWNPG5
Recce Pharmaceuticals Ltd. is engaged in the research and development of pharmaceutical drugs that kill germs. It produces antibiotics that are effective in attacking disease-causing Gram-positive and Gram-negative bacteria. The company was founded on April 11, 2007 and is headquartered in Sydney, Australia.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of RCE is 0.445 AUD — it has decreased by −1.11% in the past 24 hours. Watch RECCE PHARMACEUTICALS LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange RECCE PHARMACEUTICALS LTD stocks are traded under the ticker RCE.
RCE stock has fallen by −7.29% compared to the previous week, the month change is a −4.71% fall, over the last year RECCE PHARMACEUTICALS LTD has showed a −16.04% decrease.
We've gathered analysts' opinions on RECCE PHARMACEUTICALS LTD future price: according to them, RCE price has a max estimate of 2.46 AUD and a min estimate of 2.46 AUD. Watch RCE chart and read a more detailed RECCE PHARMACEUTICALS LTD stock forecast: see what analysts think of RECCE PHARMACEUTICALS LTD and suggest that you do with its stocks.
RCE stock is 3.41% volatile and has beta coefficient of −0.76. Track RECCE PHARMACEUTICALS LTD stock price on the chart and check out the list of the most volatile stocks — is RECCE PHARMACEUTICALS LTD there?
Today RECCE PHARMACEUTICALS LTD has the market capitalization of 103.18 M, it has decreased by −5.88% over the last week.
Yes, you can track RECCE PHARMACEUTICALS LTD financials in yearly and quarterly reports right on TradingView.
RECCE PHARMACEUTICALS LTD is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
RCE net income for the last half-year is −10.20 M AUD, while the previous report showed −7.46 M AUD of net income which accounts for −36.69% change. Track more RECCE PHARMACEUTICALS LTD financial stats to get the full picture.
No, RCE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, RCE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RECCE PHARMACEUTICALS LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RECCE PHARMACEUTICALS LTD technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RECCE PHARMACEUTICALS LTD stock shows the sell signal. See more of RECCE PHARMACEUTICALS LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.